Advancing nanopore sensors for faster, cheaper molecule identification
Official title: Advancing the analytical infrastructure of dual-nanopore time-of-flight (ToF) sensors
Funded at University of Kansas Lawrence · NIH-11336091 · Data updated 2026-11-12
A patient-friendly project to help develop a fast, low-cost device that can identify single molecules without labels, which could speed diagnoses and personalized treatment in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Lawrence NIH-funded |
| Lab location | 1 site (Lawrence, United States) |
| Project start | September 16, 2015 |
| Project end | March 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $317,348 |
| NIH project number | 2P41EB020594-12 |
| Project ID | NIH-11336091 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal for researchers and clinicians developing molecular diagnostics, with a focus on translating sensor tech to patient care.
✕Less likely to help
Direct patient benefit may be limited until translation to clinical tests; early-stage technology development may not yet affect care.
What this research studies
This project builds improved dual-nanopore ToF sensors to measure single molecules in a nanofluidic chip. It focuses on making the technology reliable, scalable, and compliant for potential clinical use. If successful, it could enable rapid, low-cost molecular tests that support precision medicine.
Why it matters
Potential benefit: Potentially faster and cheaper molecular testing that could inform personalized care.
How similar studies have gone: Other nanopore sensor efforts have shown promise, but the ToF dual-pore approach remains innovative.
Where this research is happening
-
University of Kansas Lawrence
Lawrence, United States Active
Researchers
- Principal investigator: Hall, Adam Roger — University of Kansas Lawrence
- Study coordinator: Hall, Adam Roger
Related research
Other NIH-funded projects on the same topics.
-
KC Youth Violence Prevention Center: A comprehensive plan to reduce youth violence
A program in Kansas City aims to reduce youth violence and deaths by applying a coordinated, community-focused approach.
-
Gene regulation and the genetic basis of complex traits (how our genes influence survival and trait differences)
Researchers are studying how genetic differences that affect gene regulation contribute to when and how people survive and reproduce, especially in natural populations.
-
Finding new treatments and understanding how congenital glycosylation disorders work
A research project aims to uncover how certain congenital glycosylation disorders develop and identify existing drugs that could help treat DPAGT1-CDG.
-
How ADP-ribosylation controls our antiviral defenses
Researchers are studying a cellular modification called ADP-ribosylation and how it helps the body fight viruses, with a focus on how coronaviruses interact with this process.
-
Chemoenzymatic synthesis to make biologically active molecules using enzyme libraries
A scientist team will develop enzyme-based methods to make complex drug-like molecules that could help fight cancer and other diseases.
-
DNA breaks and repair in opioid addiction
This project looks at how DNA damage and repair in brain cells may influence opioid addiction and relapse in people and animal models.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.